Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

Lucid Group reaches the finals of the PM360 2020 Trailblazer Initiative Awards

Lucid Group has been named as a finalist in the PM360 2020 Trailblazer Initiative Awards in the HCP Education category, for the program LiBRA 2019: Looking beyond the joint in...

Lucid Group Communications Limited

- PMLiVE

GSK doses first patients in phase 3 meningitis vaccine trial

Clinical programme will test five-in-one vaccine candidate

- PMLiVE

Britain ramps up COVID-19 testing to track spread of infections

Regular testing will increase from 28,000 people per fortnight to 150,000 by October

Sanofi reception

Sanofi bolsters pipeline with $3.7bn deal for Principia Biopharma

French drugmaker will gain access to a portfolio of BTK inhibitors

- PMLiVE

Vaccine nationalism must be prevented, says WHO director-general

Tedros Adhanom Ghebreyesus warns against supply nationalism

- PMLiVE

Matt Hancock unveils new National Institute for Health Protection

Public Health England to be replaced with new government body

- PMLiVE

Evoke KYNE promotes Dante DelVecchio to senior VP

DelVecchio takes on the role after ten years at Evoke KYNE

- PMLiVE

McCann Health North America appoints Jim Joseph as president

Joseph will oversee all North American advertising and promotion agencies in the US and Canada

- PMLiVE

BMS pays $475m for Dragonfly’s IL-12 immunotherapy programme

Agreement will focus on development in oncology and haematology

- PMLiVE

A senior level promotion in scientific services at Porterhouse Medical

Porterhouse is delighted to announce the promotion of Emma Conran

Porterhouse Medical Group

- PMLiVE

US states claim Purdue Pharma owes $2.2 trillion over opioid crisis

Company faces new accusations of dishonest marketing tactics

AstraZeneca AZ

AZ scores FDA priority review for new Imfinzi fixed-dose regimen

Four-week dosing schedule offers new flexibility for patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links